Influence of different routes of administration on the cardiovascular effects of dihydrexidine (DHX) in rats

T. H. Wu, K. W. Locke, S. B. Loar, T. J. Maher

Research output: Contribution to journalArticle

Abstract

The intranasal (IN) route of administration may provide more rapid and complete delivery of various pharmacological agents to the CNS, while minimizing the peripherally-mediated non-therapeutic actions of such agents. We demonstrated previously that IN administration of the dopaminergic agonist DHX produced robust contralateral turning behavior in a 6-hydroxydopamine unilateral striatal lesioned rat model. Here, we evaluate the hypotensive side effects of DHX administered IN or IV. Male Sprague-Dawley rats were anesthetized with urethane and the right carotid artery and left jugular vein cannulated for mean arterial pressure (MAP) measurement and IV drug delivery, respectively. Rats then received either IN or IV DHX or vehicle. The peak changes in MAP following 0.5, 1.0, 2.0 and 6.0 mg/kg of IN DHX were -5 ± 2, -6 ± 3, -12 ± 3 and -7 ± 3 mmHg, respectively, while following 0.25, 0.5, 0.75 mg/kg of IV DHX peak MAP changes were -22 ± 2, -25 ± 3, -28 ± 3 mmHg, respectively. The IN doses of DHX used, while previously shown to produce robust CNS effects, produced significantly less unwanted cardiovascular effects compared with the IV route. The potential utility of IN DHX should be further explored in human disorders that benefit from CNS dopaminergic stimulation such as Parkinson's disease.

Original languageEnglish
JournalFASEB Journal
Volume12
Issue number5
Publication statusPublished - Mar 20 1998
Externally publishedYes

Fingerprint

Rats
Intranasal Administration
Arterial Pressure
Corpus Striatum
Oxidopamine
Urethane
Dopamine Agonists
Jugular Veins
Pressure measurement
dihydrexidine
Drug delivery
Carotid Arteries
Sprague Dawley Rats
Parkinson Disease
Pharmacology
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Influence of different routes of administration on the cardiovascular effects of dihydrexidine (DHX) in rats. / Wu, T. H.; Locke, K. W.; Loar, S. B.; Maher, T. J.

In: FASEB Journal, Vol. 12, No. 5, 20.03.1998.

Research output: Contribution to journalArticle

@article{93f76644d4fe42e3b35c577f935f2a34,
title = "Influence of different routes of administration on the cardiovascular effects of dihydrexidine (DHX) in rats",
abstract = "The intranasal (IN) route of administration may provide more rapid and complete delivery of various pharmacological agents to the CNS, while minimizing the peripherally-mediated non-therapeutic actions of such agents. We demonstrated previously that IN administration of the dopaminergic agonist DHX produced robust contralateral turning behavior in a 6-hydroxydopamine unilateral striatal lesioned rat model. Here, we evaluate the hypotensive side effects of DHX administered IN or IV. Male Sprague-Dawley rats were anesthetized with urethane and the right carotid artery and left jugular vein cannulated for mean arterial pressure (MAP) measurement and IV drug delivery, respectively. Rats then received either IN or IV DHX or vehicle. The peak changes in MAP following 0.5, 1.0, 2.0 and 6.0 mg/kg of IN DHX were -5 ± 2, -6 ± 3, -12 ± 3 and -7 ± 3 mmHg, respectively, while following 0.25, 0.5, 0.75 mg/kg of IV DHX peak MAP changes were -22 ± 2, -25 ± 3, -28 ± 3 mmHg, respectively. The IN doses of DHX used, while previously shown to produce robust CNS effects, produced significantly less unwanted cardiovascular effects compared with the IV route. The potential utility of IN DHX should be further explored in human disorders that benefit from CNS dopaminergic stimulation such as Parkinson's disease.",
author = "Wu, {T. H.} and Locke, {K. W.} and Loar, {S. B.} and Maher, {T. J.}",
year = "1998",
month = "3",
day = "20",
language = "English",
volume = "12",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "5",

}

TY - JOUR

T1 - Influence of different routes of administration on the cardiovascular effects of dihydrexidine (DHX) in rats

AU - Wu, T. H.

AU - Locke, K. W.

AU - Loar, S. B.

AU - Maher, T. J.

PY - 1998/3/20

Y1 - 1998/3/20

N2 - The intranasal (IN) route of administration may provide more rapid and complete delivery of various pharmacological agents to the CNS, while minimizing the peripherally-mediated non-therapeutic actions of such agents. We demonstrated previously that IN administration of the dopaminergic agonist DHX produced robust contralateral turning behavior in a 6-hydroxydopamine unilateral striatal lesioned rat model. Here, we evaluate the hypotensive side effects of DHX administered IN or IV. Male Sprague-Dawley rats were anesthetized with urethane and the right carotid artery and left jugular vein cannulated for mean arterial pressure (MAP) measurement and IV drug delivery, respectively. Rats then received either IN or IV DHX or vehicle. The peak changes in MAP following 0.5, 1.0, 2.0 and 6.0 mg/kg of IN DHX were -5 ± 2, -6 ± 3, -12 ± 3 and -7 ± 3 mmHg, respectively, while following 0.25, 0.5, 0.75 mg/kg of IV DHX peak MAP changes were -22 ± 2, -25 ± 3, -28 ± 3 mmHg, respectively. The IN doses of DHX used, while previously shown to produce robust CNS effects, produced significantly less unwanted cardiovascular effects compared with the IV route. The potential utility of IN DHX should be further explored in human disorders that benefit from CNS dopaminergic stimulation such as Parkinson's disease.

AB - The intranasal (IN) route of administration may provide more rapid and complete delivery of various pharmacological agents to the CNS, while minimizing the peripherally-mediated non-therapeutic actions of such agents. We demonstrated previously that IN administration of the dopaminergic agonist DHX produced robust contralateral turning behavior in a 6-hydroxydopamine unilateral striatal lesioned rat model. Here, we evaluate the hypotensive side effects of DHX administered IN or IV. Male Sprague-Dawley rats were anesthetized with urethane and the right carotid artery and left jugular vein cannulated for mean arterial pressure (MAP) measurement and IV drug delivery, respectively. Rats then received either IN or IV DHX or vehicle. The peak changes in MAP following 0.5, 1.0, 2.0 and 6.0 mg/kg of IN DHX were -5 ± 2, -6 ± 3, -12 ± 3 and -7 ± 3 mmHg, respectively, while following 0.25, 0.5, 0.75 mg/kg of IV DHX peak MAP changes were -22 ± 2, -25 ± 3, -28 ± 3 mmHg, respectively. The IN doses of DHX used, while previously shown to produce robust CNS effects, produced significantly less unwanted cardiovascular effects compared with the IV route. The potential utility of IN DHX should be further explored in human disorders that benefit from CNS dopaminergic stimulation such as Parkinson's disease.

UR - http://www.scopus.com/inward/record.url?scp=33749217910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749217910&partnerID=8YFLogxK

M3 - Article

VL - 12

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 5

ER -